HMCC Completes Add-On Investment in CareAbout
Amsterdam, 9th of October 2025 – HMCC, a portfolio company of Holland Capital, proudly announces the successful completion of an add-on investment in CareAbout. This step brings together two strong organizations, joining forces to further support healthcare providers in ensuring continuity of care.
Joining forces
For many years, HMCC has been an innovative medical contact center, supporting general practitioners, pharmacies, and clinics remotely. By adding CareAbout to the group, the two companies can take significant steps together to enhance support for GP practices, pharmacies, and clinics across the Netherlands — both on-site and remotely.
Patrick Eliasar, CEO of HMCC, said: “This partnership enables us to serve our clients even better. By joining forces with CareAbout, we not only broaden our range of services, but also strengthen our team and our shared mission to ensure continuity of care.”
Timothy Hoolhorts, CEO of CareAbout, added: “We are very excited to take this step together with HMCC. This partnership allows us to expand our services and support healthcare organizations more comprehensively — from communication services to staffing solutions.”
Sterre Witteveen, Investment Manager at Holland Capital, commented: “We are impressed by the strong performance of both companies and see great added value in their combination. This partnership aligns perfectly with our broad healthcare portfolio, in which we consistently invest in innovative companies that improve the quality and accessibility of care.”
About HMCC
HMCC specializes in delivering remote healthcare services. The company supports pharmacies, GP practices, and clinics with experienced remote medical assistants, pharmacy assistants, and nurses. HMCC’s services ensure optimal accessibility, efficient workflows, and continuity of care.
About CareAbout
CareAbout recruits and places healthcare professionals with GP practices, pharmacies, and other primary care organizations. It offers both flexible and permanent placements, with personal guidance and professional development opportunities for its healthcare providers.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector. The company has been actively supporting HMCC in its operational and strategic development since joining as a shareholder in 2023.
Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery
Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery Eindhoven, June 16, 2020 – Sirius Medical, a MedTech startup, announced that it has received CE mark approval for Sirius Pintuition. With its debut...
Sirius Medical ontvangt CE-markering voor Pintuition: een niet radioactief lokalisatiesysteem ter verbetering van borstkankeroperaties
Sirius Medical ontvangt CE-markering voor Pintuition: een niet-radioactief lokalisatiesysteem ter verbetering van borstkankeroperaties Eindhoven, 16 Juni 2020 Sirius Medical, een medtech startup, kondigt aan dat het CE-markering heeft ontvangen voor Sirius...
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers Eindhoven, The Netherlands - 22 April 2020, - CytoSMART Technologies is to donate 100 mini live-cell imaging systems to researchers in high containment labs worldwide. Labs working to...
Yenlo benoemd tot Platinum VAR, de hoogste WSO2 Reseller status
Yenlo benoemd tot Platinum VAR, de hoogste WSO2 Reseller statusYenlo is benoemd tot WSO2 Platinum Value-Added Reseller als erkenning voor de behaalde successen en het leveren van de beste opensource integratie- en API-managementoplossingen gebaseerd op het WSO2...
Yenlo Achieves Highest WSO2 Reseller Status as a Platinum VAR
Yenlo Achieves Highest WSO2 Reseller Status as a Platinum VAR Yenlo was named a WSO2 Platinum Value-Added Reseller in recognition of its success in growing global customer adoption and delivering best-in-class open source integration and API management solutions based...
Portfolio company Inno4Life sold to the Swiss company Dec Group
Portfolio company Inno4Life sold to the Swiss company Dec Group Amsterdam, April 16, 2020 - Earlier this month, Inno4Life, a manufacturer of machines for the pharmaceutical industry, was sold to the Swiss Dec Group. Inno4Life's management will remain actively involved...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl